Next Article in Journal
NLRX1 Enhances Glutamate Uptake and Inhibits Glutamate Release by Astrocytes
Next Article in Special Issue
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
Previous Article in Journal
Global Responses of Il-1β-Primed 3D Tendon Constructs to Treatment with Pulsed Electromagnetic Fields
Previous Article in Special Issue
The Hippo Pathway in Prostate Cancer
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessFeature PaperReview

Hippo Pathway in Mammalian Adaptive Immune System

1
Department of Molecular Enzymology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan
2
Center for Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan
3
Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST), Kawaguchi 332-0012, Japan
*
Author to whom correspondence should be addressed.
Cells 2019, 8(5), 398; https://doi.org/10.3390/cells8050398
Received: 7 April 2019 / Revised: 26 April 2019 / Accepted: 28 April 2019 / Published: 30 April 2019
(This article belongs to the Special Issue Disease and the Hippo Pathway: Cellular and Molecular Mechanisms)
  |  
PDF [2355 KB, uploaded 30 April 2019]
  |     |  

Abstract

The Hippo pathway was originally identified as an evolutionarily-conserved signaling mechanism that contributes to the control of organ size. It was then rapidly expanded as a key pathway in the regulation of tissue development, regeneration, and cancer pathogenesis. The increasing amount of evidence in recent years has also connected this pathway to the regulation of innate and adaptive immune responses. Notably, the Hippo pathway has been revealed to play a pivotal role in adaptive immune cell lineages, as represented by the patients with T- and B-cell lymphopenia exhibiting defective expressions of the pathway component. The complex regulatory mechanisms of and by the Hippo pathway have also been evident as alternative signal transductions are employed in some immune cell types. In this review article, we summarize the current understanding of the emerging roles of the Hippo pathway in adaptive immune cell development and differentiation. We also highlight the recent findings concerning the dual functions of the Hippo pathway in autoimmunity and anti-cancer immune responses and discuss the key open questions in the interplay between the Hippo pathway and the mammalian immune system. View Full-Text
Keywords: Hippo pathway; innate immunity; adaptive immunity; cancer immunity; autoimmunity; YAP (yes-associated protein); TAZ (transcriptional co-activator with PDZ-binding motif); LATS (large tumor suppressor kinase); MST (mammalian STE20-like protein kinase) Hippo pathway; innate immunity; adaptive immunity; cancer immunity; autoimmunity; YAP (yes-associated protein); TAZ (transcriptional co-activator with PDZ-binding motif); LATS (large tumor suppressor kinase); MST (mammalian STE20-like protein kinase)
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Yamauchi, T.; Moroishi, T. Hippo Pathway in Mammalian Adaptive Immune System. Cells 2019, 8, 398.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top